Skip to content

Preoperative Oral Carbohydrate Treatment Minimizes Insulin Resistance

Preoperative Oral Carbohydrate Treatment in Diabetes Patients: A Randomized, Double-blind Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03658564
Enrollment
80
Registered
2018-09-05
Start date
2018-09-30
Completion date
2019-01-31
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance

Keywords

Insulin resistance, Diabetes mellitus, Carbohydrate

Brief summary

Insulin resistance is a positive protective reaction against surgery .this resistance has some negative consequences for patient health. It is associated with infectious complications. At the same time, Postoperative insulin resistance has been shown to correlate with the length of postoperative stay in hospital. Recently several clinical studies have shown that a carbohydrate-rich drink given 2 h before surgery diminishes postoperative insulin resistance in patient. The aim of our study is to investigate the influence on insulin resistance in patient with diabetes.

Detailed description

Insulin resistance is a positive protective reaction against surgery . As a response to surgery, activation of neuroendocrine and inflammation systems occurs as a protective reaction. However, this resistance has some negative consequences for patient health. It is associated with infectious complications. At the same time, Postoperative insulin resistance has been shown to correlate with the length of postoperative stay in hospital. Recently several clinical studies have shown that a carbohydrate-rich drink given 2 h before surgery diminishes postoperative insulin resistance in patient. The aim of our study is to investigate the influence on insulin resistance in patient with diabetes.

Interventions

Patients in Oral carbohydrate group consumed 400 ml Preoperative Oral Carbohydrate Drink Nutricia preOp® (12.5% carbohydrates, 0.5kcal/ml, 240 mOsm, pH 4.9, Nutricia Zoetermeer, the Netherlands) 3 hours prior to induction of anesthesia and finished the ingestion within 20 minutes.

Sponsors

The Second Affiliated Hospital of Dalian Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* patients underwent elective open colorectal resection for colorectal carcinoma and electric orthopedic surgery

Exclusion criteria

* Weight loss greater than 10 per cent during the previous 6 months * Renal insufficiency (creatinine, \> 3 mg/dl; hemodialysis) * Hepatic insufficiency (Child-Pugh class, ≥ B) * Gastro-oesophageal reflux disease * Gastrointestinal obstruction or conditions (including pharmacological treatment) known to affect gastric emptying rate

Design outcomes

Primary

MeasureTime frameDescription
VAS1 day (preoperative period)Preoperative general well-beings before assessed with the visual analogue scale (VAS).

Secondary

MeasureTime frameDescription
HOMAperioperative period)Preoperative insulin resistance before and immediately after the surgery assessed with the homeostasis model assessment (HOMA)

Countries

China

Contacts

Primary Contactyang z Xiao, MD,PhD
xiaozhaoy@163.com0866-17709873399

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026